arrow
Back
C

Claire Harrison

Department of Haematology

80H-index
848Paper Count
3.5WCitation Count
Published Papers 163
Publication Date
A phase 1 study of VAC85135, a neoantigen vaccine regimen targeting calreticulin and JAK2 mutations, in combination with ipilimumab in patients with myeloproliferative neoplasms
err2026-08-24
err0
errOAAI
errSalman Otoukesh; Bethan Psaila; Andrew Kuykendall; Aaron T. Gerds; Ahmed Abdulgawad; Prithviraj Bose; Charlotte Van Bogaert; Jennifer Bishop; Patrick Wilkinson; Baolian Liu; Tianxiang Kevin Han; Busola Sanusi; Jaymala Patel; Katelyn D. Miller; Denis Smirnov; John T. Loffredo; M. Alejandro Sepulveda; Ricardo Attar; Kim Staquet; Charles G. Drake; Nikki Daskalakis; Claire Harrison
errShare
errSave
errShare
errSave
Ruxolitinib treatment in patients with polycythemia vera reduces <i>JAK2</i> variant allele frequency and improves symptom burden and hematocrit control
err2026-03-24
err0
PREAI
errClaire N. Harrison; Jean-Jacques Kiladjian; J. E. Hamer-Maansson; Ahmad Naim; Francesca Palandri; Francesco Passamonti
errShare
errSave
Common Themes and Uncertainties in Management of Secondary Polycythaemia: An International Clinician Survey of Practice
err2025-12-01
err2
errOAAI
errNicolson, Phillip L. R.; Asif, Midhat; Buka, Richard J.; Dyer, Peter; Hassan, Eman; Harrison, Claire N.; Maybury, Bernard D.; Doyle, Andrew J.
errShare
errSave
Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline
err2025-12-01
err0
errOAAI
errGodfrey, Anna L.; Khan, Alesia A.; McGregor, Andrew; Innes, Andrew J.; Altohami, Mohammed; Cross, Nicholas C. P.; Frewin, Rebecca; Garg, Mamta; Green, Anna; Grinfeld, Jacob; McLornan, Donal P.; Wilson, Andrew J.; Harrison, Claire N.; Mead, Adam J.; Nangalia, Jyoti
errShare
errSave
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis
err2025-11-24
err0
errOAAI
errMonia Marchetti; Alessandro Maria Vannucchi; John O. Mascarenhas; Alberto Alvarez-Larran; Prithviraj Bose; Robert Peter Gale; Claire Harrison; Rűdiger Hehlmann; Jean-Jacques Kiladjian; Steffen Koschmieder; Ruben Mesa; Francesco Passamonti; Alessandro Rambaldi; Ayalew Tefferi; Tiziano Barbui
errShare
errSave
Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22/CD40
errBlood
IF23.1
err2025-10-03
err0
PREAI
errWilliam J Tapper; Ahmed A Z Dawoud; Joannah Score; Andrew J Chase; E Joanna Baxter; Joanne Ewing; Louise Wallis; Paola Guglielmelli; Dolors Colomer; Beatriz Bellosillo; Montse Gomez; Juan Carlos Hernández-Boluda; Carlos Besses; Francisco Cervantes; Steffen Koschmieder; Anthony R Green; Andreas Reiter; Alessandro Vannucchi; Claire Harrison; Nicholas C P Cross
errShare
errSave
Mesenchymal stromal cells from JAK2V617F myeloproliferative neoplasms support healthy and malignant hematopoiesis in a humanized scaffold model in vivo
err2025-08-22
err0
errOAAI
errAlessandra Ferrelli; Syed Mian; Marion Piganeau; Hector Huerga Encabo; Despoina Papazoglou; Giuseppe D'Agostino; Fatihah Mohamad Nor; Manuel Garcia-Albornoz; Steven Ngo; Linda Ariza-McNaughton; Erika Morsia; Matteo Giovanni Della Porta; Claire Harrison; Shahram Kordasti; Dominique Bonnet
errShare
errSave
QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms
errLeukemia
IF13.4
err2025-07-24
err0
errOAAI
errAndrea Duminuco; Raj Vaghela; Sukhraj Virdee; Claire Woodley; Susan Asirvatham; Natalia Curto-Garcia; Priya Sriskandarajah; Jennifer O’Sullivan; Hugues de Lavallade; Deepti Radia; Shahram Kordasti; Giuseppe A. Palumbo; Claire Harrison; Patrick Harrington
errShare
errSave
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study
err2025-07-04
err0
errOAAI
errSteffen Koschmieder; Clemens Schulte; Eyck von der Heyde; Lambert Busque; Françoise Boyer-Perrard; Timothy Devos; Francesco Passamonti; Wendy Y. Cheng; Mu Cheng; Marja Nuortti; Volker Baum; Claire Harrison
errShare
errSave
ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis
err2025-05-09
err0
errOAAI
errDavid M. Ross; Florian H. Heidel; Andrew Charles Perkins; Andreas Reiter; Carl Crodel; Caroline Riley; María Teresa Gómez-Casares; Istvan Takacs; Heiko Becker; Thomas Lehmann; Olga Vinogradova; Kate Burbury; Alessandro M. Vannucchi; Vikas Gupta; Marielle Wondergem; Jean-Jacques Kiladjian; Grace Cleary; Angela Zhang; Jagannath Kota; Anirudh Prahallad; Monika Wroclawska; Min Lu; Claire N. Harrison
errShare
errSave
Polycythaemia vera
err2025-04-17
err0
PREAI
errHarrison, Claire N.; Barbui, Tiziano; Bose, Prithviraj; Kiladjian, Jean-Jacques; Mascarenhas, John; McMullin, Mary Frances; Mesa, Ruben; Vannucchi, Alessandro M.
errShare
errSave
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial
err2025-03-10
err2
errOAAI
errRampal, Raajit K.; Grosicki, Sebastian; Chraniuk, Dominik; Abruzzese, Elisabetta; Bose, Prithviraj; Gerds, Aaron T.; Vannucchi, Alessandro M.; Palandri, Francesca; Lee, Sung-Eun; Gupta, Vikas; Lucchesi, Alessandro; Oh, Stephen T.; Kuykendall, Andrew T.; Patriarca, Andrea; alvarez-Larran, Alberto; Mesa, Ruben; Kiladjian, Jean-Jacques; Talpaz, Moshe; Scandura, Joseph M.; Lavie, David; Harris, Morgan; Kays, Sarah-Katharina; Li, Qing; Boxhammer, Rainer; Brown, Barbara; Jegg, Anna-Maria; Harrison, Claire N.; Mascarenhas, John
errShare
errSave
Improvement in Serum Albumin As a Measure of Improved Metabolic Profile in Pacritinib-Treated Patients: A Retrospective Analysis of Patients Treated across Three Clinical Trials
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errPalandri, Francesca; Sobas, Marta; Harrison, Claire; Rampal, Raajit; Buckley, Sarah; Suthar, Purvi; Roman-Torres, Karisse; Mascarenhas, John O.
errShare
errSave
Imetelstat Versus Best Available Therapy in Patients with Intermediate-2 or High-Risk Myelofibrosis Relapsed or Refractory to Janus Kinase Inhibitor in IMpactMF, a Randomized, Open-Label, Phase 3 Trial
errBLOOD
IF23.1
err2024-11-05
err3
PREAI
errMascarenhas, John O.; Harrison, Claire; Bose, Prithviraj; Kiladjian, Jean-Jacques; Lucchesi, Alessandro; Vannucchi, Alessandro Maria; Berry, Tymara; Riggs, Jennifer; Peng, Lixian; Huang, Fei; Wan, Ying; Rodolf, Vivian; Ho, Judy; Navada, Shyamala; Komrokji, Rami S.
errShare
errSave
RUX-AZA Response in AP/BP-MPN Is Driven By Release of the Differentiation Block in Mutant HSPCs: A Single-Cell Multi-Omic Analysis of Responders on the Phase Ib Phazar Study
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errBrierley, Charlotte K.; Gaskell, Charlotte; Harrison, Claire; Yap, Christina; Jackson, Aimee; Byrne, Jennifer; Hamblin, Angela; Clark, Sally-Ann; Sullivan, Jennifer O.; Rodriguez-Meira, Alba; Murphy, Lauren; Clarke, Fiona Jane; Narayanan, Srinivasan; Bowen, David T.; Gudgin, Emma; Milojkovic, Dragana; Collings, Rebecca; Psaila, Bethan; Knapper, Steve; Drummond, Mark W.; Mead, Adam J.
errShare
errSave
Clinical Relevance of the Integrative Analysis of Gut Microbiome and Metabolomics in Myeloid Neoplasms: Correlations with Genomic Profiles, Treatment Response/Complications and Clinical Outcome
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errCampagna, Alessia; Clasen, Frederick; Portlock, Theo; Zampini, Matteo; Ficara, Francesca; Crisafulli, Laura; Brindisi, Matteo; Martano, Giuseppe; Saba, Elena; Ubezio, Marta; Russo, Antonio; Todisco, Gabriele; Maggioni, Giulia; Lanino, Luca; Buizza, Alessandro; Pinocchio, Nicole; Ventura, Denise; Viviani, Filippo; Torre, Elena; Dos Reis, Rita Antunes; Rocchi, Ettore; Castellani, Gastone; Uhlen, Mathias; Harrison, Claire; Kordasti, Shahram; Della Porta, Matteo Giovanni; Shoaie, Saeed
errShare
errSave
Real World Efficacy and Safety of Momelotinib for Myelofibrosis: Evaluation of a UK-Wide Study Confirms 40% Anaemia Response Rate in a Non-Clinical Trial Cohort
errBLOOD
IF23.1
err2024-11-05
err2
PREAI
errRampotas, Alexandros; Torre, Elena; Carter-Brzezinski, Luke; Duminuco, Andrea; Cadman-Davies, Llywelyn; Chee, Ashlyn; Panitsas, Fotios; Alimam, Samah; Milojkovic, Dragana; Kaczmarski, Richard; Fraser, Louise; Frewin, Rebecca; Foley, Kate; Hockings, Catherine; Khan, Alesia; Williams, Rhys; Ryan, Jennifer; Yip, Kawai; Thaw, Kyaw Htin; Sheikh, Amna; Wadelin, Frances; Godfrey, Anna L.; Teh, Chun Huat; Wilson, Andrew J.; Lambert, Jonathan; Mead, Adam J.; Mclornan, Donal P.; Innes, Andrew J.; Mcgregor, Andrew; Somervaille, Tim; Harrison, Claire; Harrington, Patrick; Psaila, Bethan
errShare
errSave
A Phase 1/2 Study of Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, in Combination with JAK Inhibitors Ruxolitinib or Momelotinib in Patients with Myelofibrosis
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errMascarenhas, John O.; Rampal, Raajit; El Chaer, Firas; Gupta, Vikas; Shimoda, Kazuya; Kiladjian, Jean-Jacques; Passamonti, Francesco; Bose, Prithviraj; Scandura, Joseph M.; Mesa, Ruben; Rein, Lindsay A. M.; Yuda, Junichiro; Ross, David M.; Devos, Timothy; Talpaz, Moshe; Hoffman, Ronald; Kabir, Sujan; Li, Zhonggai; Foulks, Jason M.; Ansaldo, Karen; Seki, Masataka; Peddagali, Vishnu; Shah, Jatin; Harrison, Claire
errShare
errSave
errShare
errSave